Prioritizing research questions on the safety of ribavirin in the treatment of respiratory syncytial virus infections.
D000395:Air Pollutants, Occupational; D000818:Animals; D006801:Humans; D016273:Occupational Exposure; D010564:Personnel, Hospital; D012136:Respiratory Syncytial Viruses; D010253:Respirovirus Infections / Q000188:drug therapy*; D012254:Ribavirin / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use / Q000633:toxicity
D000395:Air Pollutants, Occupational; D012254:Ribavirin